| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/18/2007 | US7270817 ACPL antibodies and methods of use thereof |
| 09/18/2007 | US7270816 Interleukins; fusion proteins; solid phase synthesis; kits |
| 09/18/2007 | US7270809 cysteine-added granulocyte colony-stimulating factor; prolongs circulating half-lives of protein therapeutics so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via cysteine |
| 09/18/2007 | CA2404248C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2007 | CA2299586C Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2185541C Cytotoxic t-cell epitopes |
| 09/18/2007 | CA2181568C Use of interleukin-12 to prevent graft versus host disease |
| 09/18/2007 | CA2144477C Pna synthesis using an amino protecting group which is labile to weak acids |
| 09/18/2007 | CA2125158C Proteolytic mixture containing escharase and method of isolating same |
| 09/18/2007 | CA2102043C Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 09/18/2007 | CA2073846C Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides |
| 09/15/2007 | CA2579507A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/15/2007 | CA2545597A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/13/2007 | WO2007103567A2 Polynucleotide encoding a maize herbicide resistance gene and methods for use |
| 09/13/2007 | WO2007103521A2 Preventing norvaline and norleucine misincorporation in recombinant proteins |
| 09/13/2007 | WO2007103515A2 Unstructured recombinant polymers and uses thereof |
| 09/13/2007 | WO2007103455A2 Genetic packages and uses thereof |
| 09/13/2007 | WO2007103383A2 Plant-specific genetic elements and transfer cassettes for plant transformation |
| 09/13/2007 | WO2007103225A2 Engineered listeria and methods of use thereof |
| 09/13/2007 | WO2007103146A2 Truncated proteins as cancer markers |
| 09/13/2007 | WO2007103048A2 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 09/13/2007 | WO2007102946A2 Crystalline polypeptides |
| 09/13/2007 | WO2007102814A2 Recombinant mammalian molecules and method for production thereof |
| 09/13/2007 | WO2007102797A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 09/13/2007 | WO2007102686A1 Peptides having activities of insulin like growth factor-1 and their uses |
| 09/13/2007 | WO2007102618A1 Nucleic acid cleaving agent |
| 09/13/2007 | WO2007102563A1 Method for determination of the effect of thrombin receptor antagonist by determination of inflammatory marker |
| 09/13/2007 | WO2007102432A1 Method for producing glycoprotein composition |
| 09/13/2007 | WO2007102410A1 Novel use of rage polypeptide |
| 09/13/2007 | WO2007102365A1 Anti-viral peptide and use thereof |
| 09/13/2007 | WO2007102355A1 Gene encoding transcriptional inducer for maltase gene and maltose transporter gene and use thereof |
| 09/13/2007 | WO2007102354A2 Gene encoding protein responsible for storage resistance of yeast and use thereof |
| 09/13/2007 | WO2007102351A1 Gene encoding glycogen synthesis initiator and use thereof |
| 09/13/2007 | WO2007101949A2 Human interferon-gamma (infgamma) variants |
| 09/13/2007 | WO2007101732A1 Peptides against autoantibodies associated with glaucoma and use of these peptides |
| 09/13/2007 | WO2007101657A1 Hepatitis c virus non structural fusion protein |
| 09/13/2007 | WO2007101602A2 Chimeric kunitz domains and their use |
| 09/13/2007 | WO2007101370A1 Use of glycoconjugate chb in preparing a medicament for preventing or treating flu or poultry influenza |
| 09/13/2007 | WO2007087492A3 Methods and compositions for modulating tocopherol and tocotrienol content in plants |
| 09/13/2007 | WO2007086932A3 Prostate stem cell antigen vaccines and uses thereof |
| 09/13/2007 | WO2007079460A3 Design of cxc chemokine analogs for the treatment of human diseases |
| 09/13/2007 | WO2007075609A3 Production of chiral materials using crystallization inhibitors |
| 09/13/2007 | WO2007073706A3 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 09/13/2007 | WO2007071850A3 Inhibition of the anti-fviii immune response |
| 09/13/2007 | WO2007071692A3 Immunogenic composition |
| 09/13/2007 | WO2007071248A8 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| 09/13/2007 | WO2007064724A3 Plants having improved growth characteristics and methods for making the same |
| 09/13/2007 | WO2007063133A3 Genes useful for the industrial production of citric acid |
| 09/13/2007 | WO2007062249A3 Potent compstatin analogs |
| 09/13/2007 | WO2007062188A3 Activin-actriia antagonists and uses for promoting bone growth |
| 09/13/2007 | WO2007059597A8 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof |
| 09/13/2007 | WO2007044607A8 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 09/13/2007 | WO2007041525A3 Method of treating pancreatitis |
| 09/13/2007 | WO2007039070A3 Polynucleotides of haemophilus parasuis and its use |
| 09/13/2007 | WO2007036945A3 Hepatocyte growth factor receptor splice variants and methods of using same |
| 09/13/2007 | WO2007025141A3 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same |
| 09/13/2007 | WO2007005738A3 Glp-1 pharmaceutical compositions |
| 09/13/2007 | WO2006113643A3 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 09/13/2007 | WO2006096989A3 Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the gly-gly-ala domain for enhanced transient gene expression |
| 09/13/2007 | WO2006096487A3 Methods and compositions for modulating tweak and fn14 activity |
| 09/13/2007 | WO2006081249A8 Conjugates of biologically active proteins having a modified in vivo half-life |
| 09/13/2007 | WO2006052991A3 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 09/13/2007 | WO2005085448A8 Canine ghrh gene, polypeptides and methdos of use |
| 09/13/2007 | WO2005074626A3 Compositions, methods and uses for a novel family of peptides |
| 09/13/2007 | WO2005049637A3 Methods for the isolation and purification of defensin polypeptides |
| 09/13/2007 | WO2005021716A3 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | WO2000061614A8 Uncoupling proteins |
| 09/13/2007 | US20070214520 wound closure or coverage systems, comprising employing the recombinant spider silk protein; artificial cartilage, tendon materials, automotive parts or parts used in the aircraft construction, which comprise the protein |
| 09/13/2007 | US20070214519 Having gene encoding enzyme that can transfer fucose residue to reducing terminal of acetylglucosamine residue of glycoprotein sugar chain |
| 09/13/2007 | US20070213768 Compositions and Devices Including Same Useful for Anastomosis |
| 09/13/2007 | US20070213512 Amyloid beta peptide analogs and assemblies thereof |
| 09/13/2007 | US20070213273 Using hedgehog protein as therapeutic for treatment of bone, reproductive, nervous system and autoimmune disorders |
| 09/13/2007 | US20070213271 Composition and method for treating hiv infection |
| 09/13/2007 | US20070213268 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis |
| 09/13/2007 | US20070213267 Peptides and Calcium Regulation in Mammalian Cells |
| 09/13/2007 | US20070213265 Kunitz-type sequences and polypeptides |
| 09/13/2007 | US20070213264 Neuregulin variants and methods of screening and using thereof |
| 09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
| 09/13/2007 | US20070213255 Novel Hyaluronan-Binding Proteins and Encoding Genes |
| 09/13/2007 | US20070213253 Synuclein Mutant Having Aggregation-Inhibitory Activity |
| 09/13/2007 | US20070212788 Methods for detecting modulators of cytokine receptor zalpha11 |
| 09/13/2007 | US20070212779 Targeting adenoviral vectors to dendritic cells |
| 09/13/2007 | US20070212757 Expression System for the B Subunit of Cholera Toxin |
| 09/13/2007 | US20070212756 Methods for treating lentivirus infections |
| 09/13/2007 | US20070212755 Novel Sequence for Improving Expression of Nucleic Acid |
| 09/13/2007 | US20070212752 Cell-free protein synthesis for controlling introduction of modification group into protein |
| 09/13/2007 | US20070212743 Assays for Determining Anticoagulant Cofactor Activity |
| 09/13/2007 | US20070212737 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders |
| 09/13/2007 | US20070212735 Using maytansinoid conjugated monoclonal antibody to treat cell proliferative disorders |
| 09/13/2007 | US20070212728 32263, a novel human biotin enzyme and uses thereof |
| 09/13/2007 | US20070212716 Nezara viridula Ecdysone Receptor |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212707 Cell cycle markers |
| 09/13/2007 | US20070212693 Factor reca from bacillus licheniformis and reca-inactivated safety stems used for biotechnological production |
| 09/13/2007 | US20070212692 Generation Of Recombinant Genes In Prokaryotic Cells By Using Two Extrachromosomal Elements |
| 09/13/2007 | US20070212691 Cytolethal Distending Toxins and Detection of Campylobacter Bacteria Using the Same as a Target |
| 09/13/2007 | US20070212686 Use Of T-Cadherin As A Target |
| 09/13/2007 | US20070212683 Co-crystals and pharmaceutical compositions comprising the same |